For the Inventor, By the Inventor

Enter inventor name

Fremont, CA, United States of America

Christopher Michael Semko

USPTO Granted Patents = 58 (Patent Applications = 8)

CIPO Patents = 3 (Patent Applications = 11)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 7.3

ph-index = 13

Forward Citations = 453(Granted Patents)

Forward Citations (Not Self Cited) = 267(Oct 12, 2025)

Inventors with similar research interests:

Company Filing History:

Elan Pharmaceuticals, Inc.

24 out of 1,309

Athena Neurosciences, Inc.

4. 13 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2013

Loading Chart...

Loading Chart...

Loading Chart...

58 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8569426 - Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds (2013-10-29),

2. 8367688 - Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 (2013-02-05),

3. 8283358 - N-sulfonamido polycyclic pyrazolyl compounds (2012-10-09),

4. 8268935 - Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds (2012-09-18),

5. 8263063 - Multimeric VLA-4 antagonists comprising polymer moieties (2012-09-11),

6. 8158642 - Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 (2012-04-17),

7. 8030328 - Imidazolone phenylalanine derivatives (2011-10-04),

8. 7973044 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2011-07-05),

9. 7968547 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2011-06-28),

10. 7794700 - Multimeric VLA-4 antagonists comprising polymer moieties (2010-09-14),

11. 7763632 - Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4 (2010-07-27),

12. 7754712 - Bridged N-cyclic sulfonamido inhibitors of gamma secretase (2010-07-13),

13. 7745454 - Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 (2010-06-29),

14. 7741328 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2010-06-22),

15. 7732609 - 5-(arylsulfonyl)-pyrazolopiperidines (2010-06-08),

Title: The Innovative Journey of Christopher Michael Semko

Introduction: Christopher Michael Semko, a talented inventor based in Fremont, CA, has made significant contributions to the field of technology through his creative and groundbreaking inventions.

Latest Patents: Christopher Michael Semko holds several patents in various technological areas, including artificial intelligence, renewable energy, and consumer electronics. His most recent patent focuses on developing a cutting-edge smart home system that integrates seamlessly with everyday devices.

Career Highlights: With a background in electrical engineering, Christopher Michael Semko has worked for leading tech companies where he honed his skills in innovation and problem-solving. His career highlights include spearheading the development of a revolutionary solar-powered charging device and receiving recognition for his contributions to the advancement of sustainable energy solutions.

Collaborations: Throughout his career, Christopher Michael Semko has collaborated with top researchers, engineers, and designers to bring his inventions to life. His collaborative efforts have led to the successful launch of several products that have had a positive impact on the tech industry.

Conclusion: Christopher Michael Semko's passion for innovation and his dedication to creating cutting-edge solutions have established him as a respected figure in the world of technology. His inventive spirit continues to drive him towards new challenges and opportunities to make a difference in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…